Acute Lymphoblastic Leukemia
📧 Sign up to get email alerts when something new happens for Acute Lymphoblastic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Telematic Cognitive Training and Mindfulness in Pediatric Patients After CAR-T Cell Therapy, Single Hematopoietic Allogeneic Transplant or Chemotherapy [NA]
A pediatric study evaluating telematic cognitive training and mindfulness after CAR-T cell therapy, a single hematopoietic allogeneic transp…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation [Phase 2]
This Phase 2 clinical trial protocol investigates a post-transplant cyclophosphamide–based graft-versus-host disease prophylaxis approach in…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: International Study for Treatment of High Risk Childhood Relapsed ALL 2010 [Phase 2]
An international Phase 2 study is investigating treatment for high-risk childhood relapsed acute lymphoblastic leukemia and is currently rec…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma [Phase 2]
A Phase 2 clinical trial of Asparaginase Erwinia chrysanthemi in combination with chemotherapy for high-risk adults with newly diagnosed acu…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: TCR Reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-ALL [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluating an allogeneic CD19-targeting CAR-T cell therapy with TCR reservation and SPPL3 gene knockout (Po…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Exercise MRI to Evaluate Cardiorespiratory Fitness in Children With Heart Disease
A University of Alberta trial is evaluating exercise MRI to assess cardiorespiratory fitness in children with heart disease and is currently…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders [Phase 2]
Phase 2 clinical trial evaluating cord blood transplant in children and young adults with blood cancers and select non-malignant disorders; …
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: HIIT in Pediatric Heart Transplant Recipients (MedBIKE™) [NA]
This clinical trial update describes a study evaluating high-intensity interval training (HIIT) using the MedBIKE device in pediatric heart …
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Venetoclax Basket Trial for High Risk Hematologic Malignancies [Phase 1]
A Phase 1 Venetoclax basket trial across multiple high-risk hematologic malignancies is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Study of the Efficacy of Moderate Sedation With Intra-NAsal Dexmedetomidine Monitored by EEG MOnitoring [NA]
Clinical trial update indicates a study of moderate sedation using intranasal dexmedetomidine monitored by EEG is currently recruiting in pe…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma [Phase 3]
Ongoing Phase 3 clinical trial evaluating levocarnitine to protect the liver from chemotherapy in children with acute lymphoblastic leukemia…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS) [Phase 2]
This is a Phase 2 clinical trial update evaluating strategies to reduce graft-versus-host disease in donor blood stem cell transplant patien…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases [NA]
This entry reports an ongoing clinical trial evaluating myeloablative preparative regimens for umbilical cord blood transplantation across s…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia [Phase 2]
A Phase 2 study evaluating ruxolitinib in combination with chemotherapy in children with acute lymphoblastic leukemia has completed enrollme…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: UCD19 CAR T Therapy in Adults With B-ALL and MRD Positivity in CR1 [Phase 1]
This clinical trial update describes a Phase 1 study of UCD19 CAR T therapy in adults with B-cell acute lymphoblastic leukemia who are MRD-p…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: NUDT15/TPMT Multi-gene Guided 6-MP Dosing in Childhood ALL Maintenance Therapy [NA]
Clinical trial update on multi-gene guided dosing with 6-mercaptopurine for maintenance therapy in childhood acute lymphoblastic leukemia; c…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant [Phase 2]
Phase 2 clinical trial evaluating CMV-MVA Triplex vaccination in HLA-matched related stem cell donors to prevent cytomegalovirus infection i…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Clinical Study on the Safety and Efficacy of BiTE-EV in Relapsed/Refractory Acute B-Cell Leukemia [EARLY_Phase 1]
An early-phase Phase 1 clinical study evaluating the safety and efficacy of BiTE-EV in relapsed/refractory acute lymphoblastic leukemia, cur…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: CD5 Chimeric Antigen Receptor (CAR) T Cells in Subjects With Relapsed or Refractory T-cell Malignancies [Phase 1, Phase 2]
An update on an ongoing Phase 1/2 clinical trial evaluating CD5-targeted CAR T cells for relapsed or refractory T-cell malignancies, includi…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Clinical Trial of CD19 and CD22 CAR Sequential Therapy Versus Single CD19 CAR Bridging to HSCT for r/r B-ALL Patients [NA]
A recruiting clinical trial is evaluating sequential CD19 and CD22 CAR-T cell therapy versus a single CD19 CAR bridging to hematopoietic ste…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: A Phase I Study of Hyper-CVAD In Combination With Venetoclax In Pediatric Patients With Relapsed or Refractory Acute Leukemias That Are of the Lymphoid Lineage Including Bi-Phenotypic or Undifferentiated Leukemias [Phase 1]
A Phase I pediatric trial evaluating Hyper-CVAD in combination with venetoclax for relapsed or refractory acute leukemias of the lymphoid li…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Phase II Study of the Combination of Subcutaneous Blinatumomab and Olverembatinib in Patients With Philadelphia Chromosome (ph)-Positive and/or BCR::ABL1 Positive Acute Lymphoblastic Leukemia (ALL) [Phase 2]
Phase II clinical trial evaluating the combination of subcutaneous blinatumomab and olverembatinib for Philadelphia chromosome-positive and/…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Pediatric Normative Markerless Movement Analysis
A pediatric clinical trial evaluating normative markerless movement analysis in patients with acute lymphoblastic leukemia and adolescents i…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders [NA]
This update reports the completed status of a trial assessing bone marrow and kidney transplant for patients with chronic kidney disease and…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: CalPeg for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) [Phase 1]
A Phase 1 clinical trial evaluating CalPeg for newly diagnosed acute lymphoblastic leukemia is currently recruiting. The study is sponsored …